Dr. Surendra Varma Appointed to Texas Medical Board District Three Review Committee

Translate to Spanish or other 102 languages!

Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
- Advertisement -

AUSTIN – Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026.

Surendra Varma, M.D. of Lubbock is the executive associate dean for graduate medical education at the Texas Tech University Health Sciences Center (TTUHSC) and is a Grover E. Murray Professor and Ted Hartman Endowed Chair in Medical Education at TTUHSC. He is an associate editor for Advances in Pediatrics, editorial board member for the Journal of Clinical Endocrinology and Metabolism, and a member of the American Pediatric Society, Society for Pediatric Research, Endocrine Society, and the Council on Graduate Medical Education for the Health Resources & Services Administration. He is a member and former president of the American Diabetes Association and a member and former Texas affiliate chair of endocrinology for the American Academy of Pediatrics. Previously, he served as a gubernatorial appointee on the TMB District Three Review Committee for six years, TMB for five years, and the Task Force on Infectious Disease Preparedness and Response for four years. Varma received a Bachelor of Science in Physics, Chemistry, Biology and English from the University of Lucknow, and a Bachelor of Medicine, a Bachelor of Surgery, and a Doctor of Medicine in Pediatrics from King George Medical University (KGMU). He has received honorary Doctorate (DSc) from KGMU and Honorary Fellowship (FRCP) from Royal College of Physicians. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -